| Benzimidazoles in drug discovery: a patent review CSW Law, KY Yeong ChemMedChem 16 (12), 1861-1877, 2021 | 59 | 2021 |
| Current trends of benzothiazoles in drug discovery: A patent review (2015–2020) CSW Law, KY Yeong Expert Opinion on Therapeutic Patents 32 (3), 299-315, 2022 | 31 | 2022 |
| Repurposing antihypertensive drugs for the management of Alzheimer’s disease CSW Law, KY Yeong Current Medicinal Chemistry 28 (9), 1716-1730, 2021 | 15 | 2021 |
| Dual‐Target‐Directed Ligand Displaying Selective Butyrylcholinesterase Inhibitory and Neurite Promoting Activities as a Potential Therapeutic for Alzheimer's Disease FM Farouk, L Ooi, CSW Law, KY Yeong ChemistrySelect 5 (36), 11229-11236, 2020 | 7 | 2020 |
| The Role of Interferon-α in Neurodegenerative Diseases: A Systematic Review BSM Hui, LR Zhi, T Retinasamy, A Arulsamy, CSW Law, MF Shaikh, ... Journal of Alzheimer’s Disease 94 (s1), S45-S66, 2023 | 5 | 2023 |
| Synthesis of novel carboxamide-and carbohydrazide-benzimidazoles as selective butyrylcholinesterase inhibitors O Ozturk, FM Farouk, L Ooi, CSW Law, MT Muhammed, E Aki-Yalcin, ... Molecular Diversity 26 (5), 2863-2876, 2022 | 5 | 2022 |
| Indazole derivatives as selective inhibitors of butyrylcholinesterase with effective blood-brain-barrier permeability profile AJ Tobuse, CSW Law, CK Thy, JJ James, CF Chee, KY Yeong Medicinal Chemistry Research 33 (2), 298-307, 2024 | 1 | 2024 |
| # 37 Design, synthesis and evaluation of the cholinesterase inhibitory potential of 5-chlorobenzimidazole derivatives for Alzheimer’s S Pathak, A Gurjar, CSW Law, KY Yeong, S Vishwakarma Journal of Pharmaceutical Chemistry 8 (Supplement), 2022 | | 2022 |
